Back to Journals » Neuropsychiatric Disease and Treatment

SJR OA

CiteScore

Impact Factor

Neuropsychiatric Disease and Treatment

ISSN: 1178-2021

Journal Articles:

- 4,668 records -

Original Research

Echinocystic Acid Antagonizes Post-Stroke Depression in Mice by Suppressing the JNK/NF-κB Signaling Pathway

Wang D, Li W, Zhang X, Zhu K, Wang Y, Cai Y, Chen H, Cai X, Sun J

Neuropsychiatric Disease and Treatment 2026, 22:596008

Published Date: 5 June 2026

Original Research

Peripheral Nerve Conduction in Alzheimer’s vs. Late-Life Depression: A Comparative Study

Li X, Zhao X, Huang Y, Tang J

Neuropsychiatric Disease and Treatment 2026, 22:611214

Published Date: 4 June 2026

Review

Integration of Traditional Chinese Medicine and Psychotherapy in Mental Health: A Narrative Review of Mechanisms, Clinical Evidence, and Future Directions

Du J, Tan Y

Neuropsychiatric Disease and Treatment 2026, 22:607443

Published Date: 3 June 2026

Review

Current Evidence of Acetyl-L-Carnitine Use in Mood Disorders-: A Systematic Review and Meta-Analysis

Kumar R, Hashempour Z, Shahriarirad S, Shahriarirad R, Hassett LC, Singh B, Croarkin PE, Veldic M, Frye MA, Pagali SR

Neuropsychiatric Disease and Treatment 2026, 22:586506

Published Date: 3 June 2026

Review

Evaluating the Role of AI Assistants in Accelerating Neurodegenerative Disease Research: Opportunities and Translational Limitations

Yu X, Yao Q

Neuropsychiatric Disease and Treatment 2026, 22:614952

Published Date: 30 May 2026

Original Research

Caregiver Mental Health and Sociodemographic Factors Associated with the Burden of Care in Taiwan Among Primary Caregivers of Patients with Major Depressive Disorder: A Cross-Sectional Study

Changchien TC, Chiu YW, Hsieh TJ, Yen YC, Wang RH, Ho YC

Neuropsychiatric Disease and Treatment 2026, 22:606026

Published Date: 28 May 2026

Review

MicroRNA-425-3p: A Promising Biomarker and Candidate for Pharmacological Intervention in Neuropsychiatric Disabilities with Relevance to Major Depressive Disorder

May L, Dwivedi Y

Neuropsychiatric Disease and Treatment 2026, 22:611548

Published Date: 20 May 2026

Review

L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders

Putri VA, Hapsari RS, Amalia R

Neuropsychiatric Disease and Treatment 2026, 22:579603

Published Date: 19 May 2026

Review

The Fractalkine (FKN/CX3CL1) Pathway in Depression: A Critical Review of Its Role in Neuroinflammation and Therapeutic Potential

YanLuan Z, Sa R, Fan Y, Jia H, Ge J, Bai S, Ma R, Tong L

Neuropsychiatric Disease and Treatment 2026, 22:607481

Published Date: 17 May 2026

Original Research

Factors Associated with Poor Health-Related Quality of Life Among Patients with Epilepsy at Mulago National Referral Hospital

Atwijukiire H, Namutundu J, Lubogo D, Kaddumukasa M, Sajatovic M

Neuropsychiatric Disease and Treatment 2026, 22:604140

Published Date: 15 May 2026

Original Research

Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia

Hu W, Huang B, Guo X, Yin X, Wang X, Ji Y, Zheng Y, Gao T, Shi C, Yu X, Pu C

Neuropsychiatric Disease and Treatment 2026, 22:603001

Published Date: 13 May 2026

Original Research

Cistanche deserticola Stem Extract Attenuates Depression Through NF-κB Pathway Modulation: Insights from Network Pharmacology and Experimental Validation

Jiang S, An Z, Hu Q, Song Y, Zhao X, Gao S, Jia Q, Xu B

Neuropsychiatric Disease and Treatment 2026, 22:586181

Published Date: 13 May 2026

Original Research

Functional Impairment and Post-Stroke Depression: Potential Roles of Sleep Quality and Fatigue in a Cross-Sectional Structural Equation Analysis

Hu QY, Yang KY, Ming YF, Sun SJ, Liu J

Neuropsychiatric Disease and Treatment 2026, 22:606661

Published Date: 12 May 2026

Study Protocol

Psychomotor Rehabilitation for Pediatric Delirium: A Study Protocol for a Randomized Controlled Trial Investigating Efficacy and Brain Electrophysiological Mechanisms

Zhang X, Ren YQ, Shan YJ, Zhou YP, Dou JY, Lu Y, Cui Y, Ao LJ

Neuropsychiatric Disease and Treatment 2026, 22:595008

Published Date: 11 May 2026

Review

Role of Electroencephalographic Biomarkers as Predictors of Post-Stroke Cognitive Outcomes in Patients with Cerebral Infarction: Literature Review

Pu D, Xiong Y

Neuropsychiatric Disease and Treatment 2026, 22:566481

Published Date: 11 May 2026

Original Research

Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm

Citrome L, Franzenburg KR, Suett M, Tohami O, Sharon N, Jehassi A, Harary E, Yu D, Correll CU

Neuropsychiatric Disease and Treatment 2026, 22:534730

Published Date: 8 May 2026

Review

Central Neurobiological Mechanisms of Acupuncture in Post-Stroke Depression: Multi-Target and Network-Based Regulation

Cao J, Xu Y, Mao H, Chen J, Ding D, Xu X

Neuropsychiatric Disease and Treatment 2026, 22:596862

Published Date: 6 May 2026

Review

Efficacy and Safety of Escitalopram for Major Depressive Disorder in Children and Adolescents: A Systematic Review and Meta-Analysis with Age-Specific Findings

Maneeton B, Maneeton N, Pojanapotha P, Putthisri S, Oon-arom A, Karawekpanyawong N, Kawilapat S, Maneeton P, Srichan K

Neuropsychiatric Disease and Treatment 2026, 22:595606

Published Date: 5 May 2026

Original Research

Peripheral Blood Regulatory T Cells and IL-6 are Associated with Cognitive Impairment After Acute Ischemic Stroke

Chang Y, Zhang X, Yu C, Zhu L, Sun S, Sun Z

Neuropsychiatric Disease and Treatment 2026, 22:590109

Published Date: 1 May 2026

Perspectives

Optimizing Identification and Management of Depression in Neurological Diseases: A Narrative Review and Expert Perspective

Bartova L, Beuster ML, Bonetti B, Maina G, Morgado P, Nyberg J

Neuropsychiatric Disease and Treatment 2026, 22:575685

Published Date: 1 May 2026

Original Research

Sleep-Related Problems and Problematic Smartphone Use in Young Adult Males: Findings from a Short-Term Behavioral Restriction Study

Özen Gökmuharremoğlu Ö, Çoban Taşkın A

Neuropsychiatric Disease and Treatment 2026, 22:597802

Published Date: 30 April 2026

Review

Insulin Resistance Across Cerebrovascular and Related Disorders: Mechanisms, Measurement, Genetics, and Clinical Implications

Chen K, Nong Y, Liu Y, Ye Z

Neuropsychiatric Disease and Treatment 2026, 22:575306

Published Date: 30 April 2026

Original Research

Association Between Frontotemporal Atrophy and Cognitive Impairment in Patients with Schizophrenia Based on Computed Tomography Imaging

Wang Y, Yang J, Ye Y, Lu L, Wang H, Guo P, Hou N, Huang X, Li C

Neuropsychiatric Disease and Treatment 2026, 22:602462

Published Date: 30 April 2026

Original Research

Long-Term Effectiveness and Safety of LCIG in Romania. 3-year Results from a Prospective, Observational Study (DUOGLOBE)

Szasz JA, Constantin VA, Jianu DC, Dan TF, Dulamea AO, Sabau M, Vasile MT, Bergmann L, Popescu D, Simu MA

Neuropsychiatric Disease and Treatment 2026, 22:564900

Published Date: 28 April 2026

Study Protocol

Clinical Efficacy of Integrated Acupuncture and Moxibustion Therapy Combined with Drugs in the Treatment of Acute Depressive Disorder: Protocol for a Pragmatic Randomized Controlled Trial

Wu Q, Liu Y, Lin D, Wang S, Liang X, Wu B, Wan L, Liu Y, Wang T, Liu H, Lai L, Sun L, Fu W

Neuropsychiatric Disease and Treatment 2026, 22:601078

Published Date: 27 April 2026

Study Protocol